Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets
Not yet recruiting · NCT07172126 · Registry updated 2025-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets | Metastatic Castration-resistant Prostate Cancer | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-15 | NCT07172126 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Affiliated to Chongqing University | Chongqing | China | 1 |
| Cancer Hospital Affiliated to Fudan University | Shanghai | China | 1 |
| The Fifth Affiliated Hospital of Sun Yat-sen University | Zhuhai | China | 21 |